Patent · US Active

Treatment for epilepsy

US9161965B2 · kind B2 · utility

3Cited by
1References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 14, 2009
Grant dateOct 20, 2015
Priority date
Expiry dateMay 21, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods of treating a patient having epilepsy in which an effective regime of an agent that inhibits specific binding of PSD-95 to an NMDA receptor is administered to a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.